2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Leukemia, Lymphocytic in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fung, KL | 1 |
| Liang, RH | 1 |
| Chan, GC | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
Topics: Antineoplastic Agents; Asparaginase; Benzamides; Bone Marrow Cells; Coculture Techniques; Drug Scree | 2010 |